Qualigen Therapeutics
Biotechnology Research
5857 Owens Avenue
32 employees
QLGN
- Employees
- 32
- Contacts
- 3
- Emails
- 3
Qualigen Therapeutics Overview
- Headquarters
- 5857 Owens Avenue
- Website
- www.qlgntx.com
- Industry
- Biotechnology Research
- Employees
- 32
- Stock Symbol
- QLGN
- Funding
- 4.5M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Qualigen Therapeutics
Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation.
Qualigen Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
Qualigen Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Mark Sarno | CEO, Vision Clinical Research, Llc | Escondido, California, United States |
View
|
| David Yeakley | Area Sales Manager at Qualigen Inc. | San Antonio, Texas, United States |
Email
|
| Mariann Artino | System Support Assistant at Qualigen | Alliance, Ohio, United States |
Email
|
| Al Rod | Qualigeninc.com | Carlsbad, California, United States |
Email
|
Employees by Management Level
Executive
1 profile
Manager
1 profile
Individual contributor
1 profile
Associate / junior
1 profile
Compare Similar Companies to Qualigen Therapeutics
Endpoint Clinical
Pharmaceutical Manufacturing
Cue Health
Biotechnology Research
Geron Corporation
Biotechnology Research
Kopran Ltd
Pharmaceutical Manufacturing
Sandu Pharmaceuticals Ltd.
Pharmaceutical Manufacturing
Qualigens Pharma Private Limited
Pharmaceutical Manufacturing
iSpecimen
Biotechnology Research
Palisade Bio
Pharmaceutical Manufacturing
ProciseDx
Hospitals And Health Care
NanoSynex
Medical And Diagnostic Laboratories